Skip to main content

EMD Millipore to Distribute Firefly BioWorks' microRNA Profiling Assay

NEW YORK (GenomeWeb News) – EMD Millipore, a division of Germany's Merck KGaA, announced this week that it has signed a deal to become the global distributor of Firefly BioWorks' SmartRNAplex microRNA profiling assay.

Specific terms of the deal were not disclosed.

According to EMD Millipore, the assay involves the hybridization of miRNA targets to probes attached to Firefly's proprietary hydrogel particles. A universal biotinylated adapter is then ligated to the captured targets, and a fluorescent reporter binds to the universal adapter. The reporter is used for miRNA detection in a flow cytometer.

"As microRNA-based research evolves from discovery to validation, robust, multiplex methods that can be performed easily at the bench are necessary to continue advancements in the field," Grace Johnston, marketing manager for EMD Millipore, said in a statement. "The SmartRNAplex assay is an important new tool for our customers who are elucidating the role of microRNAs in a broad range of human diseases and need to explore multiple targets across many samples."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.